Clinical Trial Update: A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas [Phase 2]

View source ↗

Summary

Phase 2 study evaluating 10 mg oral mifepristone for symptomatic uterine fibroids was terminated; the update notes the trial status and does not report final ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Mifepristone (RU-486) (mifepristone)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Leiomyoma | Phase 2 | Status: TERMINATED